Phenotypes for Dictyostelium mutants
BACK TO DOWNLOADS INDEX
To view more details, including parent strains and references, click on the corresponding dictyBase ID.
| Strain ID |
Strain Descriptor |
Associated gene(s) |
Strain Name(s) |
Phenotypes |
| DBS0252824 | dstA-/GFP: dstA(237-707): ORF+/[act15]: 2C | 2C, dstA | Dd-STATa, STATa | aberrant fruiting body morphology |
| DBS0238601 | 5NT- | 5NT | | delayed tip formation, multiple tips in culminant, multiple tips in mound |
| DBS0252823 | dstA-/GFP: dstA(237-707): ORF+/[act15]: 7E | 7E, dstA, hssB | Dd-STATa, NK20-like, STATa | wild type |
| HAD186 | aarA- | aarA | aar | aberrant fruiting body morphology, decreased sporulation |
| DBS0266687 | abiA- | abiA | Abi2 | aberrant cytokinesis, aberrant protein localization, decreased chemotaxis to folate, decreased growth rate, decreased protein level |
| DBS0266688 | abiA- | abiA | Abi2 | aberrant protein localization |
| DBS0235426 | abpC-/[act15]: abpC | abpC | ABP-120, ABP120, FLN, ddFLN, gelA | wild type |
| DBS0236077 | abpC- | abpC | ABP-120, ABP120, FLN, ddFLN, gelA | aberrant phototaxis, aberrant thermotaxis |
| DBS0237938 | abpC-/[act15]: GFP: abpC(9-148) | abpC | ABP-120, ABP120, FLN, ddFLN, gelA | aberrant phototaxis |
| DBS0237941 | abpC-/[act15]: abpC(1-739): GFP | abpC | ABP-120, ABP120, FLN, ddFLN, gelA | aberrant phototaxis |
| DBS0237945 | abpC-/[act15]: abpC(1-348: 449-857): GFP | abpC | ABP-120, ABP120, FLN, ddFLN, gelA | aberrant F-actin organization, aberrant phototaxis |
| DBS0237946 | abpC-/[act15]: abpC(1-556: 644-857): GFP | abpC | ABP-120, ABP120, FLN, ddFLN, gelA | aberrant F-actin organization, aberrant phototaxis |
| DBS0237948 | abpC-/[ecmA]: abpC: GFP | abpC | ABP-120, ABP120, FLN, ddFLN, gelA | wild type |
| DBS0237949 | abpC-/[cotB]: abpC: GFP | abpC | ABP-120, ABP120, FLN, ddFLN, gelA | aberrant phototaxis |
| DBS0235427 | abpD- | abpD | | aberrant development, decreased cell-cell adhesion, decreased spore viability, delayed development |
| DBS0235428 | abpE- | abpE | Dabp1 | increased lateral pseudopod formation |
| DBS0235430 | acaA- | acaA | ACA | aberrant F-actin organization, aberrant cell morphology, decreased chemotaxis rate, increased lateral pseudopod formation |
| DBS0235562 | acaA- | acaA | ACA | abolished aggregation |
| TL177 | acbA- | acbA | | abolished SDF production, abolished sorting to prestalk region, decreased spore viability |
| DBS0235440 | acgA- | acgA | ACG | precocious spore germination |
| DBS0237788 | acgA- | acgA | ACG | decreased gene expression, decreased prespore cell differentiation |
| DBS0237786 | acrA-/[act15]: acgA(1-401) | acgA, acrA | ACB, ACG, ACR, DG1100 | decreased gene expression, decreased prespore cell differentiation, decreased sporulation |
| DBS0237790 | acgA-/[acrA]: lacZ | acgA, acrA | ACB, ACG, ACR, DG1100 | mislocalized gene expression |
| DG1100 | acrA- | acrA | ACB, ACR, DG1100 | decreased gene expression, decreased sporulation, increased stalk length, spores inviable |
| DBS0238203 | adrm1- | adrm1-1 | adrm1 | aberrant response to nutrients, precocious development, precocious gene expression |
| DBS0235457 | ahhA- | ahhA | | aberrant culminant morphology |
| DBS0238600 | alp- | alp | aplA | wild type |
| DBS0235473 | alrA-/[act15]: alrA | alrA | | wild type |
| DBS0235513 | alrA- | alrA | | decreased cell motility, decreased cytosolic glucose level, decreased extracellular counting factor component(s) level, increased aggregate size |
| DBS0235474 | alxA- | alxA | ALIX, DdAlix, alx | aberrant fruiting body morphology, decreased growth rate, development arrests at loose aggregate stage |
| DBS0235475 | alxA- | alxA | ALIX, DdAlix, alx | aberrant fruiting body morphology, abolished sporulation, decreased gene expression, development arrests at mound stage |
| DBS0235476 | alxA-/[act15]: alxA(1-596): myc2 | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235477 | alxA-/[act15]: alxA(1-697): myc2 | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235478 | alxA-/[act15]: alxA(155-697): myc2 | alxA | ALIX, DdAlix, alx | aberrant fruiting body morphology |
| DBS0235479 | alxA-/[act15]: alxA(293-697): myc2 | alxA | ALIX, DdAlix, alx | aberrant fruiting body morphology |
| DBS0235480 | alxA-/[act15]: alxA(460-794): myc2 | alxA | ALIX, DdAlix, alx | aberrant fruiting body morphology |
| DBS0235481 | alxA-/[act15]: alxA(D310A/N311A) | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235482 | alxA-/[act15]: alxA(Q181E/Q183) | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235483 | alxA-/[act15]: alxA(S700A/S704A/S708A) | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235484 | alxA-/[act15]: alxA(S700D/S704D/S708D) | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235485 | alxA-/[act15]: alxA(Y315D) | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235486 | alxA-/[act15]: alxA(Y315F) | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235487 | alxA-/[act15]: alxA: myc2 | alxA | ALIX, DdAlix, alx | wild type |
| DBS0235488 | alxA-/[act15]: FLAG: alxA | alxA | ALIX, DdAlix, alx | delayed development |
| DBS0235489 | alyA- | alyA | | increased phagocytosis |
| DG1114 | amdA- | amdA | | decreased spore viability, increased prestalk A cell differentiation, translucent sorus |
| HM1158 | amdA- | amdA | | decreased sporulation, increased aspidocyte differentiation, small fruiting body |
| DBS0235490 | amiB- | amiB | | abolished aggregation |
| DBS0235491 | amiB- | amiB | | abolished aggregation, abolished down-regulation of growth phase genes, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis to cAMP, decreased gene expression |
| DBS0235493 | ampA- | ampA | D11, pegA | decreased prestalk cell differentiation, delayed development, delayed gene expression, delayed tip formation, increased cell-cell adhesion, increased cell-substrate adhesion, mislocalized gene expression, precocious gene expression |
| BS155 | amtA- | amtA | | decreased aggregate size, decreased slug migration, increased growth rate, small fruiting body |
| BS154 | amtC- | amtC | | aberrant fruiting body morphology, aberrant protein localization, decreased gene expression, delayed culmination, development arrests at slug stage, mislocalized gene expression |
| DBS0235501 | amtC-/[act15]: cudA | amtC, cudA | | delayed culmination |
| DBS0235502 | amtC-/[ecmA]: cudA | amtC, cudA | | delayed culmination |
| DBS0235503 | amtC-/[pspA]: cudA | amtC, cudA | | development arrests at slug stage |
| DBS0235505 | apm1- | apm1 | | aberrant contractile vacuole organization and biogenesis, aberrant endosome morphology, aberrant response to hypo-osmotic stress, decreased growth rate, decreased spore germination, decreased stalk width, delayed development |
| DBS0235507 | apm3- | apm3 | | aberrant endosome morphology |
| DBS0235508 | apm4- | apm4 | | wild type |
| DBS0235509 | aprA- | aprA | 60T, Ncf60 | aberrant cytokinesis, aberrant fruiting body morphology, decreased spore viability, decreased sporulation, increased aggregate size, increased growth rate |
| DBS0235511 | arkA- | arkA | ARCK-1 | aberrant fruiting body morphology, increased gene expression |
| DBS0235514 | aslA- | aslA | | wild type |
| HR131 | atg1- | atg1 | APG1 | aberrant cellular response to nitrogen starvation, abolished aggregation, abolished macroautophagy, abolished sporulation, abolished stalk cell differentiation, decreased growth rate in suspension, decreased growth rate on bacterial plates, increased number of autophagosomes |
| DBS0236304 | atg1- | atg1 | APG1 | aberrant macroautophagy, abolished autophagic vacuole formation |
| DBS0236305 | atg1- | atg1 | APG1 | aberrant macroautophagy, abolished autophagic vacuole formation |
| DBS0238085 | atg1-/[act15]: atg1 | atg1 | APG1 | wild type |
| DBS0238087 | atg1-/[act15]: atg1(K36A) | atg1 | APG1 | aberrant cellular response to nitrogen starvation, abolished aggregation |
| DBS0238092 | atg1-/[act15]: atg1(1-628) | atg1 | APG1 | aberrant cellular response to nitrogen starvation, abolished aggregation |
| DBS0238093 | atg1-/[act15]: atg1(P138S) | atg1 | APG1 | abolished aggregation |
| HR75 | atg5- | atg5 | APG5 | aberrant cellular response to nitrogen starvation, aberrant macroautophagy, abolished aggregation, abolished sporulation, multiple tips |
| HR174 | atg6- | atg6A | APG6, atg6 | aberrant cellular response to nitrogen starvation, aberrant macroautophagy, decreased sporulation, decreased stalk length, multiple tips, small fruiting body |
| HR79 | atg7- | atg7 | APG7 | aberrant cellular response to nitrogen starvation, aberrant macroautophagy, abolished sporulation, multiple tips |
| HR141 | atg8- | atg8 | APG8 | aberrant cellular response to nitrogen starvation, aberrant macroautophagy, aberrant spore morphology, decreased sporulation, multiple tips, small fruiting body |
| TL97 | cadA- | cadA | CAD1, DdCAD-1, GP24, rcdD, veg102 | decreased sporulation, delayed culmination, increased prestalk cell differentiation, multiple tips |
| DG1056 | lipB- | captC | DG1056, lipB | aberrant fruiting body morphology |
| DBS0235570 | carB- | carB | cAR2 | development arrests at mound stage |
| DBS0235568 | car4- | carD | cAR4 | aberrant fruiting body morphology, decreased gene expression, increased gene expression |
| DBS0235573 | carmil- | carmil | | decreased aggregate size, decreased basal F-actin level, decreased growth rate, decreased pinocytosis |
| DBS0235574 | catB- | catB | | delayed development, spores hypersensitive to H2O2 (peroxide) |
| HC423 | cbpA- | cbpA | CBP1 | decreased cell motility, delayed aggregation, increased aggregate size |
| DBS0235575 | cbpJ- | cbpJ | CBP10 | wild type |
| DBS0235578 | cdk8-/[cdk8]: cdk8 | cdk8 | CDK, Ddcdk8 | wild type |
| DBS0235661 | cdk8- | cdk8 | CDK, Ddcdk8 | abolished aggregation, decreased gene expression, mislocalized gene expression |
| DBS0235584 | CF45-1- | cf45-1 | | decreased aggregate size, decreased cell motility, increased aggregate size, increased cell-cell adhesion, increased cytosolic glucose level |
| DBS0235585 | CF50- | cf50-1 | cf50 | decreased extracellular counting factor component(s) level, increased aggregate size, increased cell-cell adhesion, increased gene expression |
| HO101 | chcA- | chcA | | aberrant cytokinesis, decreased growth rate, decreased pinocytosis |
| HO103 | AX2/chcA- | chcA | | aberrant fruiting body morphology, abolished cytokinesis, abolished gene expression, abolished growth in suspension, abolished sporulation, delayed aggregation |
| DBS0235589 | chcA-/[cotB]: lacZ | chcA | | mislocalized gene expression |
| DBS0235590 | chcA-/[ecmA]: lacZ | chcA | | mislocalized gene expression |
| DBS0235591 | chcA-/[ecmB]: lacZ | chcA | | mislocalized gene expression |
| DBS0235592 | chcA-/[pspA]: lacZ | chcA | | mislocalized gene expression |
| DBS0235588 | chcA-/[act15]: GFP: mhcA | chcA, mhcA | MHC | decreased positive regulation of GTPase activity |
| DBS0235596 | ChLim- | ChLim | | increased growth rate, increased phagocytosis |
| DBS0235601 | clc- | clc | clcA | aberrant fruiting body morphology, aberrant response to hypo-osmotic stress, abolished cytokinesis, abolished growth |
| DBS0235604 | clc-/[act15]: GFP-clc(146-194) | clc | clcA | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0235605 | clc-/[act15]: GFP-clc(85-124) | clc | clcA | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0235607 | clc-/[act15]GFP: clc(1-124) | clc | clcA | aberrant fruiting body morphology, abolished cytokinesis, wild type |
| DBS0235608 | clmA- | clmA | | aberrant response to hypo-osmotic stress |
| DBS0235612 | CMFR1- | cmfB | CMFR1 | abolished aggregation, decreased gene expression |
| DBS0235613 | cnrB- | cnrB | | wild type |
| HG1770 | cnxA- | cnxA | | decreased extracellular Ca2+ uptake, increased cytosolic Ca2+ response |
| DBS0235615 | cofB- | cofB | DCOF2 | wild type |
| DBS0235616 | cofC- | cofC-1 | DCOF3, cofC | wild type |
| DG1016 | comB- | comB | DG1016, ORF1016 | abolished culmination |
| DBS0235617 | comB- | comB | DG1016, ORF1016 | abolished culmination |
| DBS0235618 | comC- | comC | | aberrant aggregation, aberrant streaming |
| DBS0235619 | comD- | comD | | abolished culmination |
| DBS0235620 | comE- | comE | | aberrant fruiting body morphology, translucent sorus |
| DBS0235622 | comG- | comG | ALDH | development arrests at mound stage, multiple tips |
| DBS0235623 | comH- | comH | gtaB | development arrests at mound stage |
| HG1569 | corA- | corA | | aberrant cell morphology, aberrant cytokinesis, decreased cell motility, decreased growth rate |
| HG1570 | corA- | corA | | aberrant cell morphology, aberrant cytokinesis, decreased cell motility, decreased growth rate |
| HG1571 | corA- | corA | | aberrant cell morphology, aberrant cytokinesis, decreased cell motility, decreased growth rate |
| TL55 | cotA- | cotA | SP96 | aberrant spore coat morphology |
| DBS0236996 | TL26 | cotB | SP70 | aberrant spore coat morphology |
| TL52 | cotC- | cotC | SP60 | aberrant spore coat morphology |
| DBS0238297 | cpnA- | cpnA | | aberrant cytokinesis, aberrant fruiting body morphology, decreased culmination, decreased growth rate, delayed development, delayed response to hypo-osmotic stress |
| DBS0238320 | cpnA-/[act15]: GFP: cpnA | cpnA | | decreased culmination, delayed development, delayed response to hypo-osmotic stress |
| DBS0235627 | crlA- | crlA | | decreased sorting to prestalk region, delayed tip formation, increased aggregate size, increased growth rate |
| DBS0235628 | crlA-/[crlA]: crlA | crlA | | increased aggregate size |
| DBS0237091 | yakA-/[crlA]: crlA | crlA, yakA | dagB | abolished growth |
| DBS0235629 | crlB- | crlB | | wild type |
| DBS0235630 | crlC- | crlC | | wild type |
| HG1768 | crtA- | crtA | | decreased extracellular Ca2+ uptake, increased cytosolic Ca2+ response |
| DBS0235633 | crtf- | CRTF | | abolished aggregation, abolished sporulation, decreased gene expression |
| WTC127 | cshA- | cshA | | decreased growth rate, decreased phagocytosis, delayed aggregation, development arrests at loose aggregate stage |
| DBS0235624 | ctnA- | ctnA | countin | decreased basal F-actin level, decreased cAMP-induced cAMP pulse, decreased myosin II assembly, decreased protein level, increased GTP-gamma-S-stimulated guanylyl cyclase activity, increased aggregate size, increased cAMP-induced cGMP pulse, increased cell motility, increased cell-cell adhesion, increased cytosolic glucose level |
| DBS0235636 | ctnB- | ctnB | countin2 | decreased gene expression, increased number of aggregates, small fruiting body |
| DG1071 | ctr9- | ctr9 | DG1071 | aberrant fruiting body morphology |
| DG1058 | ctrA- | ctrA | DG1058 | small fruiting body |
| HS1151 | ctxA- | ctxA | | aberrant cytokinesis, decreased growth rate |
| DBS0235598 | ctxA- | ctxA | | aberrant cell morphology, aberrant cytokinesis |
| DBS0237536 | ctxA-/[act15]: enlA(92-497) | ctxA, enlA | enlazin, fimB, fimbrin-2 | wild type |
| DBS0237568 | ctxA-/[RNAi]enlA | ctxA, enlA | enlazin, fimB, fimbrin-2 | wild type |
| DBS0237564 | mhcA-/[act15]: GFP: ctxA/[RNAi]enlA | ctxA, enlA, mhcA | MHC, enlazin, fimB, fimbrin-2 | aberrant cytokinesis, contractile ring contraction |
| DBS0235600 | ctxB- | ctxB | FPS1 | aberrant cell morphology, aberrant cytokinesis |
| DBS0235639 | cudA- | cudA | | abolished sporulation, abolished stalk cell differentiation, decreased gene expression, development arrests at slug stage |
| DBS0235640 | culA- | culA | | development arrests at tipped mound stage, multiple tips |
| DBS0235641 | culA-/[cotC]: culA | culA | | decreased sporulation, decreased stalk length, increased sorus size |
| DBS0235642 | culA-/[ecmA]: culA | culA | | decreased stalk length, increased sorus size |
| DBS0235643 | culA-/[pkaC]pkaC | culA, pkaC | DdPK2, DdPK3, PK2, PK3, PKA, PKA-C, cAK, pkacat | wild type |
| DBS0235651 | cybA- | cybA | p22phox | aberrant development, abolished sporulation |
| AK108 | dagA- | dagA | CRAC, synag7 | abolished activation of adenylate cyclase, abolished aggregation, abolished gene expression, decreased gene expression |
| DBS0235652 | dagA-/[act15]: dagA | dagA | CRAC, synag7 | wild type |
| DBS0252637 | DAip1- | DAip1 | AIP1, WRP2, rcdA, veg150, wdpA | decreased growth rate, decreased phagocytosis, decreased pinocytosis, delayed cytokinesis |
| DBS0235653 | darA- | darA | | abolished aggregation, decreased aggregate size |
| TL127 | dcsA- | dcsA | | aberrant spore coat morphology, abolished cellulose biosynthesis, abolished sporulation, abolished stalk cell differentiation, abolished stalk formation |
| TL128 | dcsA-/[act15]: dcsA | dcsA | | wild type |
| DG1099 | dcsA- | dcsA | | aberrant spore coat morphology, abolished cellulose biosynthesis, abolished sporulation, abolished stalk cell differentiation, abolished stalk formation |
| DG1128 | dcsA- | dcsA | | aberrant spore coat morphology, abolished cellulose biosynthesis, abolished sporulation, abolished stalk formation |
| DBS0235659 | DD3-3- | DD3-3 | | decreased gene expression, precocious aggregation |
| DBS0266700 | Dd5P1- | Dd5P1 | PI5P1 | wild type |
| DBS0235660 | Dd5P2- | Dd5P2 | PI5P2 | increased basal F-actin level, wild type |
| DBS0266702 | Dd5P3- | Dd5P3 | PI5P3 | wild type |
| DBS0266692 | Dd5P4- | Dd5P4 | PI5P4, RacGAP | decreased engulfment during phagocytosis, decreased growth rate, decreased phagocytosis, multiple tips in mound |
| DBS0266693 | Dd5P4-/[act15]: Dd5P4 | Dd5P4 | PI5P4, RacGAP | wild type |
| DBS0266694 | Dd5P4-/[act15]: cat5P4 | Dd5P4 | PI5P4, RacGAP | decreased growth rate, multiple tips in mound |
| DBS0266695 | Dd5P4-/[act15]: GAP5P4 | Dd5P4 | PI5P4, RacGAP | decreased growth rate, multiple tips in mound |
| DBS0266719 | Dd5P4-/[act15]: Dd5P4: GFP | Dd5P4 | PI5P4, RacGAP | wild type |
| DBS0266720 | Dd5P4-/[act15]: Hs-OCRL | Dd5P4 | PI5P4, RacGAP | decreased phagocytosis |
| DBS0266721 | Dd5P4-/[act15]: Hs-OCRL(D422A) | Dd5P4 | PI5P4, RacGAP | decreased phagocytosis |
| DG1003 | DG1003- | DG1003 | ORF1003 | aberrant culminant morphology |
| DG1007 | DG1007- | DG1007 | ORF1007 | abolished culmination |
| DG1039 | DG1039- | DG1039 | ORF1039 | aberrant fruiting body morphology |
| DG1040 | DG1040- | DG1040 | | aberrant fruiting body morphology |
| DG1041 | DG1041- | DG1041 | ORF1041 | aberrant fruiting body morphology |
| DG1054 | DG1054- | DG1054 | | aberrant fruiting body morphology |
| DG1060 | DG1060- | DG1060 | ORF1060 | aberrant fruiting body morphology |
| DG1062 | DG1062- | DG1062 | | aberrant fruiting body morphology |
| DG1074 | DG1074- | DG1074 | | aberrant fruiting body morphology |
| DG1080 | DG1080- | DG1080 | | aberrant fruiting body morphology |
| DG1091 | DG1091- | DG1091 | | small fruiting body |
| DG1098 | DG1098- | DG1098 | | small fruiting body |
| DG1104 | DG1104- | DG1104 | DG1104 | abolished aggregation |
| DG1105 | DG1105- | DG1105 | | abolished aggregation |
| DG1106 | DG1106- | DG1106 | | abolished aggregation |
| DG1110 | DG1110- | DG1110 | | aberrant fruiting body morphology |
| DG1112 | DG1112- | DG1112 | RasGAP | decreased stalk width |
| DG1113 | DG1113- | DG1113 | | increased stalk length |
| DG1122 | DG1122- | DG1122 | | aberrant fruiting body morphology |
| DG1124 | DG1124- | DG1124 | | development arrests at loose aggregate stage |
| DG2033 | DG2033- | DG2033 | | development arrests at mound stage |
| DG2044 | DG2044- | DG2044 | | development arrests at loose aggregate stage |
| DBS0235695 | dgkA- | dgkA | MHC-PKC, MHCK | aberrant development, decreased chemotaxis rate, decreased spore viability, increased myosin II assembly |
| AK299 | dhkA- | dhkA | | aberrant fruiting body morphology, aberrant stalk morphogenesis, decreased sporulation, increased gene expression, increased sporulation in the presence of 8-Br-cAMP, mislocalized gene expression |
| DBS0235704 | dhkB- | dhkB | | precocious spore germination |
| TL135 | dhkC- | dhkC | | decreased spore germination, precocious aggregation, precocious culmination, precocious development |
| DBS0235710 | dhkK- | dhkK | smbA, sombrero | aberrant slug migration, delayed culmination, delayed gene expression |
| DBS0235712 | dhkK-/[act15]: dhkK(D1125N) | dhkK | smbA, sombrero | aberrant fruiting body morphology |
| DBS0235706 | regA-/[act15]: dhkK(D1125N) | dhkK, regA | DG1030, DdPDE2, pde2, smbA, sombrero | aberrant fruiting body morphology, precocious development |
| DBS0235708 | regA-/[act15]: dhkK(H825Q) | dhkK, regA | DG1030, DdPDE2, pde2, smbA, sombrero | aberrant fruiting body morphology, precocious development |
| DBS0235895 | dimA- | dimA | bzpA | aberrant fruiting body morphology, abolished prestalk cell differentiation, decreased prestalk O cell differentiation, increased prespore cell differentiation, increased slug size, long fingers, thin fingers |
| DBS0235903 | dimB-/[act15]: dimA: GFP | dimA, dimB | bzpA, bzpB | abolished nuclear protein localization |
| DBS0235901 | dimB- | dimB | bzpB | abolished response to DIF |
| DBS0235902 | dimB-/[cotB]: lacZ | dimB | bzpB | increased prespore cell differentiation |
| DBS0235904 | dimB-/[act15]: dimB: GFP | dimB | bzpB | wild type |
| DBS0235906 | dimB-/[ecmAO]: lacZ | dimB | bzpB | decreased prestalk O cell differentiation |
| DBS0235907 | dimB-/[ecmO]: lacZ | dimB | bzpB | aberrant prestalk cell differentiation |
| DBS0235913 | dmpA- | dmpA | Dmp1 | aberrant fruiting body morphology, aberrant streaming, decreased sporulation, decreased stalk cell differentiation, delayed development, translucent sorus |
| HM1030 | dmtA- | dmtA | | aberrant fruiting body morphology, abolished DIF production, abolished prestalk O cell differentation |
| DBS0235914 | dnapkcs- | dnapkcs | DNA-PKcs, PRKDC | increased sensitivity to DNA-damaging agents |
| DBS0235915 | dng1- | dng1 | | decreased growth rate, delayed aggregation |
| DBS0235916 | dnmA- | dnmA | | aberrant culminant morphology, decreased cytosine methylation in genomic DNA, decreased sporulation, translucent sorus |
| DBS0235917 | dnmA- | dnmA | | decreased cytosine methylation in genomic DNA |
| DG2015 | docA- | docA | DG1012, DG2016, timA | development arrests at mound stage |
| DBS0235920 | dokA- | dokA | | aberrant response to hyperosmotic stress, decreased sporulation, translucent sorus |
| HAD172 | dpoA- | dpoA | | aberrant development |
| HAD200 | dpoA- | dpoA | | aberrant development |
| HAD201 | dpoA- | dpoA | | aberrant development |
| HAD202 | dpoA- | dpoA | | aberrant development |
| HAD203 | dpoA- | dpoA | | aberrant development |
| DBS0238474 | drkC- | drkC | rk3, vsk3 | decreased phagocytosis, decreased phagolysosome formation |
| DBS0238475 | drkC-/[act15]: drkC: YFP | drkC | rk3, vsk3 | wild type |
| DBS0238511 | drkC-/[act15]: drkC(1-497): YFP | drkC | rk3, vsk3 | decreased phagocytosis |
| DBS0238513 | drkC-/[act15]: drkC(K518R): YFP | drkC | rk3, vsk3 | decreased phagocytosis |
| DBS0235924 | dscA- | dscA-1, dscA-2 | dscA | aberrant cell morphology |
| DBS0235925 | dstA- | dstA | Dd-STATa, STATa | aberrant fruiting body morphology, abolished gene expression, abolished sorting to prestalk region, abolished stalk cell differentiation, decreased cell motility, decreased gene expression, delayed aggregation, increased gene expression, mislocalized gene expression |
| DBS0235926 | dstA- | dstA | Dd-STATa, STATa | aberrant fruiting body morphology, abolished sorting to prestalk region, abolished stalk cell differentiation, decreased cell motility, delayed aggregation, mislocalized gene expression |
| DBS0235928 | dstA-/[act15]: dstA | dstA | Dd-STATa, STATa | wild type |
| DBS0235929 | dstA-/[cprB]: dstA | dstA | Dd-STATa, STATa | wild type |
| DBS0235930 | dstA-/[ecmAO]: dstA | dstA | Dd-STATa, STATa | wild type |
| DBS0238237 | dstA-/GFP: dstA(237-707): ORF+ | dstA | Dd-STATa, STATa | abolished culmination, decreased stalk length |
| DBS0238236 | dstA-/GFP: dstA(237-707): ORF+/[OE]dutA | dstA, dutA | Dd-STATa, STATa | wild type |
| DBS0252826 | dstA-/GFP: dstA(237-707): ORF+/[act15]: geneDDB0231646 | dstA, geneDDB0231646 | Dd-STATa, STATa | aberrant fruiting body morphology |
| DBS0252825 | dstA-/GFP: dstA(237-707): ORF+/[act15]: geneDDB0252771 | dstA, geneDDB0252771 | Dd-STATa, STATa | aberrant fruiting body morphology |
| DBS0252816 | dstA-/GFP: dstA(237-707): ORF+/[act15]: hssA | dstA, hssA | Dd-STATa, NK20, STATa | wild type |
| DBS0235931 | dstB- | dstB | Dd-STATb, STATb | decreased gene expression, decreased growth rate, increased gene expression |
| DBS0235933 | dstB-/[act15]: dstB | dstB | Dd-STATb, STATb | wild type |
| DBS0235934 | dstB-/[act15]: dstB(L1025R) | dstB | Dd-STATb, STATb | wild type |
| DBS0235935 | dstB-/[act15]: dstB(Y1143F) | dstB | Dd-STATb, STATb | wild type |
| DBS0235936 | dstC- | dstC | Dd-STATc, STATc | mislocalized gene expression, precocious development, precocious gene expression |
| DBS0235937 | dtfA- | dtfA | | aberrant cytokinesis, aberrant fruiting body morphology, delayed tip formation |
| DBS0238234 | dutA- | dutA | | wild type |
| DBS0235939 | dwwA- | dwwA | | aberrant F-actin organization, aberrant cell morphology, aberrant cytokinesis |
| DBS0235940 | EB1- | eb1 | | aberrant mitosis, increased aneuploidy |
| HJW117 | ecmA- | ecmA | pDd63 | long fingers, thin fingers, weak slime trail |
| HJW01 | ecmB- | ecmB | 253, SC253, pDd56 | wild type |
| HJW03 | ecmB- | ecmB | 253, SC253, pDd56 | wild type |
| DBS0235944 | ecmF- | ecmF | | wild type |
| DBS0235946 | egeB- | egeB | DG2005, R2005, orfR2005 | development arrests at mound stage |
| DBS0235947 | eppA- | eppA | | decreased chemotaxis to cAMP, decreased chemotaxis to folate, decreased growth rate, decreased intracellular cAMP level, delayed development |
| DBS0235948 | eppA-/[act6]: myc: eppA | eppA | | wild type |
| AK240 | erkB- | erkB | dagC, erk2 | abolished aggregation, decreased cAMP-induced cAMP pulse, decreased sporulation |
| HS174 | erkB- | erkB | dagC, erk2 | abolished aggregation, decreased cAMP-induced cAMP pulse, decreased sporulation |
| DBS0235951 | fadA- | fadA | des5-1 | increased resistance to heat shock |
| DBS0235952 | fadB- | fadB | des5-2 | wild type |
| DBS0236034 | fam45- | fam45 | | wild type |
| DBS0236040 | fam91- | fam91 | | wild type |
| DBS0235953 | fbxA- | fbxA | chtA | decreased sporulation |
| DBS0235954 | fbxA-/[ecmA]: GFP(S65T) | fbxA | chtA | increased prespore cell differentiation |
| DBS0235956 | fbxA1- | fbxA | chtA | aberrant fruiting body morphology, delayed culmination, development arrests at slug stage, increased slug migration |
| DBS0235957 | fbxA2- | fbxA | chtA | aberrant fruiting body morphology, delayed culmination, development arrests at slug stage, increased slug migration |
| DBS0235958 | fbxA3- | fbxA | chtA | aberrant fruiting body morphology, delayed culmination, development arrests at slug stage, increased slug migration |
| DG1148 | fcpA- | fcpA | DG1148, fcp1 | aberrant fruiting body morphology |
| DBS0235960 | fcsA- | fcsA | LC-FACS 1 | decreased fatty acid accumulation |
| DBS0235961 | fimA- | fimA | fim, p67, plastin | decreased cell size |
| DBS0235966 | forA- | forA | | wild type |
| DBS0235968 | forB- | forB | | wild type |
| DBS0235969 | forC- | forC | | aberrant fruiting body morphology, abolished slug migration |
| DBS0235970 | forH- | forH | dDia2, drf2 | decreased cell-substrate adhesion, decreased filopodium formation, increased cell motility |
| DBS0235971 | forH-/[act15]: GFP: forH | forH | dDia2, drf2 | decreased cell motility, increased cell-substrate adhesion, increased filopodium formation |
| DBS0235976 | fszA- | fszA | FtsZ | decreased number of mitochondria, increased number of tubular mitochondria |
| DBS0235980 | fszB- | fszB | FtsZ | decreased growth rate, decreased number of mitochondria, increased number of tubular mitochondria |
| DG1066 | fut1- | fut1 | futA | aberrant fruiting body morphology |
| DG1094 | gacT- | gacT | DG1094, RacGAP | aberrant fruiting body morphology |
| DBS0235989 | gadA- | gadA | | abolished SDF production, decreased sporulation |
| DBS0235990 | gbf- (TL198) | gbfA | GBF | abolished gene expression, development arrests at mound stage |
| DBS0235994 | gbpC- | gbpC | gefT | decreased myosin light chain kinase activation, small fruiting body |
| DBS0235995 | gbpC- | gbpC | gefT | aberrant cell morphology, aberrant myosin II organization, decreased cell polarity, decreased chemotaxis rate, small fruiting body |
| DBS0235997 | gbpD- | gbpD | RapGEF, gefU | decreased cell-substrate adhesion, decreased lateral pseudopod formation, increased cell polarity, increased chemotaxis rate |
| DBS0235998 | gbpD-/[act15]: gbpD | gbpD | RapGEF, gefU | aberrant F-actin organization, abolished aggregation, decreased chemotaxis rate, increased cell-substrate adhesion, increased lateral pseudopod formation |
| DBS0237617 | myoI-/[act15]: gbpD | gbpD, myoI | DdMVII, M7, MVII, RapGEF, gefU | aberrant cell morphology, increased cell-substrate adhesion, increased pseudopod formation |
| DBS0237615 | phg2-/[act15]: gbpD | gbpD, phg2 | RapGEF, gefU | aberrant cell morphology, abolished chemotaxis to cAMP, increased pseudopod formation |
| DBS0237614 | rasC-/[act15]: gbpD | gbpD, rasC | RapGEF, gefU | aberrant cell morphology, increased cell-substrate adhesion |
| DBS0237616 | talA-/[act15]: gbpD | gbpD, talA | RapGEF, gefU | aberrant cell morphology, increased cell-substrate adhesion, increased pseudopod formation |
| DG1120 | gbqA- | gbqA | DG1120 | aberrant fruiting body morphology |
| DBS0236002 | gcsA- | gcsA | GCS, gshA | abolished gene expression, cell cycle arrest, development arrests at mound stage, inviable, spores inviable |
| DBS0236003 | gcsA-/[act15]: gcsA | gcsA | GCS, gshA | decreased spore viability, development arrests at mound stage |
| DBS0236004 | gdt1- | gdt1 | gdtA | decreased growth rate in suspension, increased gene expression, precocious aggregation |
| DBS0237190 | gdt1-/[act15]: pkaR(G135E/G261A) | gdt1, pkaR | PKA, cAK, gdtA, rdeC | abolished aggregation, increased gene expression |
| DBS0236006 | gdt2- | gdt2 | | increased gene expression, precocious aggregation |
| JB10 | gefA- | gefA | RasGEF, RasGEFA, aimless, aleA | abolished aggregation |
| RI19 | gefA- | gefA | RasGEF, RasGEFA, aimless, aleA | abolished activation of adenylate cyclase, abolished aggregation, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemoattractant-mediated F-actin polymerization, decreased chemotaxis rate |
| DBS0236009 | gefB- | gefB | RasGEF, RasGEFB | aberrant cell morphology, aberrant cytoskeleton organisation, aberrant fruiting body morphology, abolished growth, abolished pinocytosis, decreased aggregate size, decreased growth rate, decreased phagocytosis, delayed aggregation, increased basal F-actin level |
| DBS0236868 | gefC- | gefC | RasGEF, racGEF | wild type |
| DBS0236869 (DBS0235543) | gefD- | gefD | RacGAP, RasGEF, RasGEFD | wild type |
| DBS0236870 | gefE- | gefE | RasGEF, RasGEFE | aberrant phototaxis, aberrant thermotaxis |
| DBS0236011 | gefG- | gefG | RasGEF, RasGEFG | wild type |
| DBS0236012 | gefK- | gefK | RasGEF, RasGEFK | wild type |
| DBS0236871 | gefL- | gefL | RasGEF, RasGEFL | aberrant phototaxis, aberrant thermotaxis |
| HSB61 | gefM- | gefM | RasGEF, RasGEFM | aberrant activation of adenylate cyclase activity, decreased cAMP-induced cAMP pulse, decreased chemotaxis rate, decreased lateral pseudopod suppression, development arrests at mound stage, increased cAMP-induced cGMP pulse |
| DBS0236014 | gefR- | gefR | RasGEF, RasGEFR | wild type |
| DBS0236019 | geneDDB0231722- | geneDDB0231722 | | wild type |
| DBS0236020 | geneDDB0231722- | geneDDB0231722 | | wild type |
| DBS0236023 | geneDDB0231730- | geneDDB0231730 | | wild type |
| DBS0236024 | geneDDB0231730- | geneDDB0231730 | | wild type |
| DBS0236025 | geneDDB0231732- | geneDDB0231732 | | wild type |
| DBS0236026 | geneDDB0231734- | geneDDB0231734 | | wild type |
| DBS0236027 | geneDDB0231758- | geneDDB0231758 | | wild type |
| DBS0236028 | geneDDB0231760- | geneDDB0231760 | | wild type |
| DBS0236029 | geneDDB0231760- | geneDDB0231760 | | wild type |
| DBS0236030 | geneDDB0231767- | geneDDB0231767 | | wild type |
| DBS0236032 | geneDDB0231825- | geneDDB0231825 | | wild type |
| DBS0236033 | geneDDB0231825- | geneDDB0231825 | | wild type |
| DBS0236035 | geneDDB0232144- | geneDDB0232144 | | wild type |
| DBS0236036 | geneDDB0232146- | geneDDB0232146 | | wild type |
| DBS0236037 | geneDDB0232147- | geneDDB0232147 | | wild type |
| DBS0236038 | geneDDB0232148- | geneDDB0232148 | | wild type |
| DBS0236039 | geneDDB0232149- | geneDDB0232149 | NELF-C/D | wild type |
| DBS0236041 | geneDDB0232151- | geneDDB0232151 | | wild type |
| DBS0236042 | geneDDB0232152- | geneDDB0232152 | | wild type |
| DBS0236043 | geneDDB0232153- | geneDDB0232153 | | wild type |
| DBS0236044 | geneDDB0232154- | geneDDB0232154 | | wild type |
| DBS0236045 | geneDDB0232155- | geneDDB0232155 | | wild type |
| DBS0236046 | geneDDB0232156- | geneDDB0232156 | | wild type |
| DBS0236049 | geneDDB0233892- | geneDDB0233892 | | wild type |
| DG1109 | ggtA- | ggtA | DG1109 | aberrant fruiting body morphology |
| DBS0236078 | glpD- | glpD | GP2, gp-2 | aberrant glycogen metabolism |
| DBS0236079 | gmsA- | gmsA | | decreased sexual fusion |
| DBS0236080 | gmsA- | gmsA | | decreased sexual fusion |
| DBS0238384 | gnt14- | gnt14 | | wild type |
| DBS0238382 | gnt15- | gnt15 | | abolished aggregation, abolished culmination, decreased gene expression, decreased growth rate, increased calcium-independent cell-cell adhesion |
| DBS0238383 | gnt15- | gnt15 | | abolished aggregation, abolished culmination, decreased gene expression, decreased growth rate, increased calcium-independent cell-cell adhesion |
| DBS0238390 | gnt15-/[act15]: FLAG: gnt15 | gnt15 | | wild type |
| DBS0238391 | gnt15-/[act15]: FLAG: gnt15 | gnt15 | | wild type |
| DBS0236082 | gol- | gol | | increased resistance to cisplatin |
| DBS0235412 | 1C7 | gp130 | | decreased cell-substrate adhesion, delayed development, increased growth rate |
| DBS0235414 | 2F5 | gp130 | | decreased cell-substrate adhesion, delayed development, increased growth rate |
| DBS0236085 | GP138C- | GP138C | fusD | wild type |
| JH131 | gpaA- | gpaA | Ga1, Galpha1, gpa1 | wild type |
| DBS0236087 | gpaA- | gpaA | Ga1, Galpha1, gpa1 | decreased stalk width, increased stalk length |
| DBS0236091 | gpaA-/[ecmB]: lacZ | gpaA | Ga1, Galpha1, gpa1 | decreased gene expression |
| DBS0236092 | gpaA-/[gpaA]: gpaA(G45V) | gpaA | Ga1, Galpha1, gpa1 | delayed development |
| DBS0236093 | gpaA-/[gpaA]: gpaA(Q206L) | gpaA | Ga1, Galpha1, gpa1 | increased basal disc size |
| JH104 | gpaB- | gpaB | Ga2, Galpha2, gpa2 | abolished activation of adenylate cyclase, abolished aggregation, decreased gene expression |
| DBS0236096 | gpaB-/[act15]: gpaB | gpaB | Ga2, Galpha2, gpa2 | abolished aggregation |
| DBS0236097 | gpaB-/[gpaA]: gpaB | gpaB | Ga2, Galpha2, gpa2 | abolished aggregation |
| DBS0236098 | gpaB-/[gpaB]: gpaB(Q208L) | gpaB | Ga2, Galpha2, gpa2 | aberrant protein localization |
| DBS0236099 | gpaB-/[gpaB]: gpaB | gpaB | Ga2, Galpha2, gpa2 | wild type |
| DBS0236575 | myc-2 (G?2-) | gpaB | Ga2, Galpha2, gpa2 | decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse |
| DBS0237137 | [act15]: gpaB(D154V)/gpaB- | gpaB | Ga2, Galpha2, gpa2 | decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237138 | [act15]: gpaB(E190G)/gpaB- | gpaB | Ga2, Galpha2, gpa2 | decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse |
| DBS0237139 | [act15]: gpaB(I104S)/gpaB- | gpaB | Ga2, Galpha2, gpa2 | decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237140 | [act15]: gpaB(L110S)/gpaB- | gpaB | Ga2, Galpha2, gpa2 | decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237142 | [act15]: gpaB(N74D)/gpaB- | gpaB | Ga2, Galpha2, gpa2 | decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis rate |
| DBS0237143 | [act15]: gpaB(R64G)/gpaB- | gpaB | Ga2, Galpha2, gpa2 | decreased chemotaxis rate |
| DBS0237144 | [act15]: gpaB(S155P)/gpaB- | gpaB | Ga2, Galpha2, gpa2 | decreased chemotaxis rate |
| DBS0235986 | G3T2 (G?3-) | gpaC | Ga3, Galpha3, gpa3 | aberrant activation of adenylate cyclase activity, abolished aggregation, decreased gene expression, increased protein kinase A activity |
| DBS0235984 | G?4- | gpaD | Ga4, Galpha4, gpa4 | aberrant fruiting body morphology, decreased gene expression, decreased sporulation |
| JH257 | gpaE- | gpaE | Ga5, Galpha5, gpa5 | delayed gene expression, delayed tip formation |
| LW1 | gpaG- | gpaG | Ga7, Galpha7, gpa7 | wild type |
| DBS0236106 | gpaG- | gpaG | Ga7, Galpha7, gpa7 | wild type |
| LW3 | gpaH- | gpaH | Ga8, Galpha8, gpa8 | wild type |
| DBS0236107 | gpaH- | gpaH | Ga8, Galpha8, gpa8 | wild type |
| DBS0236108 | gpaH- | gpaH | Ga8, Galpha8, gpa8 | wild type |
| DBS0236109 | gpaI- | gpaI | Ga9, Galpha9, gpa9 | decreased aggregate size, increased number of aggregates, precocious aggregation, small fruiting body |
| LW5 | gpbA- | gpbA | Gb, Gbeta | abolished aggregation |
| LW6 | gpbA- | gpbA | Gb, Gbeta | aberrant protein localization, decreased CRAC translocation, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased chemotaxis to cAMP, decreased chemotaxis to folate, decreased positive regulation of Ras GTPase activity |
| DBS0236112 | grlE- | grlE | DdmGluPR | abolished SDF production, decreased sporulation |
| DBS0236113 | grlE- | grlE | DdmGluPR | aberrant gene expression, decreased chemotaxis to cAMP, delayed aggregation |
| DBS0238865 | grlJ- | grlJ | | aberrant spore morphology, decreased spore viability, increased slug size, precocious development, precocious gene expression, small fruiting body |
| DBS0238866 | grlJ-/[act15]: grlJ: GFP | grlJ | | wild type |
| DBS0238686 | grpA- | grpA | GRASP, GRASP55, gorasp2 | abolished protein secretion, decreased spore germination |
| DBS0238687 | grpA-/[act15]: grpA-FLAG | grpA | GRASP, GRASP55, gorasp2 | wild type |
| HM338 | gskA- | gskA | GSK-3, GSK3 | aberrant fruiting body morphology, decreased prespore cell differentiation, decreased sporulation, increased prestalk cell differentiation, precocious aggregation |
| ARK200 | gskA- | gskA | GSK-3, GSK3 | decreased gene expression, decreased sporulation, increased gene expression |
| DBS0236114 | gskA- | gskA | GSK-3, GSK3 | aberrant sorus morphology, decreased slug migration, decreased stalk length |
| DBS0236120 | gxcA- | gxcA | RacGEF, RacGEF1 | decreased chemoattractant-mediated F-actin polymerization, decreased positive regulation of Rac GTPase activity, delayed development |
| DBS0236121 | gxcB- | gxcB | RacGEF, Trix | aberrant cytoskeleton organisation, decreased exocytosis, delayed development |
| DBS0238825 | gxcDD- | gxcDD | RacGEF | aberrant streaming, delayed development |
| DBS0236129 | hbx2- | hbx2 | hbx-2 | wild type |
| DBS0236130 | hbx2- | hbx2 | hbx-2 | wild type |
| DBS0236153 | hcpA- | hcpA | | decreased growth rate in suspension at low temperature |
| DBS0236157 | hcpB- | hcpB | | wild type |
| HM444 | helC- | helC | ddx19 | aberrant fruiting body morphology, decreased gene expression, delayed development |
| HM1012 | helC- | helC | ddx19 | aberrant fruiting body morphology, decreased gene expression, delayed development |
| DG1059 | helE- | helE | DG1059 | increased slug migration |
| DBS0236163 | helF- | helF | | delayed development, increased gene silencing by RNA interference, increased slug size, increased stalk cell differentiation |
| DBS0252818 | hssA- | hssA | NK20 | wild type |
| DBS0252699 | icmA- | icmA-1, icmA-2 | ICMT, icmA | aberrant cAMP wave formation, aberrant fruiting body morphology, aberrant protein localization, aberrant signal transduction during aggregation, abolished cell polarity, abolished growth, abolished sporulation, abolished streaming, delayed gene expression, development arrests at mound stage |
| DBS0252700 | icmA-/[act15]: icmA | icmA-1, icmA-2 | ICMT, icmA | wild type |
| DBS0252701 | icmA-/[act15]: hICMT | icmA-1, icmA-2 | ICMT, icmA | wild type |
| DBS0252702 | icmA-/[act15]: TAP: YFP: rasG | icmA-1, icmA-2, rasG | ICMT, ddRASG, icmA | abolished C-terminal protein amino acid methylation |
| DBS0236421 | icpA- | icpA | DdINCENP, INCENP | aberrant cytokinesis, aberrant mitosis, aberrant protein localization |
| DBS0236547 | mhcA-/[unk]: GFP: icpA | icpA, mhcA | DdINCENP, INCENP, MHC | aberrant protein localization |
| BS153 | ifkA- | ifkA | | decreased extracellular counting factor component(s) level, increased aggregate size, precocious aggregation, precocious gene expression |
| BS160 | ifkB- | ifkB | | increased gene expression |
| DBS0236425 | ino1- | ino1 | ISYNA1, MIPS | abolished growth, decreased intracellular myo-inositol level, decreased phagocytosis, increased intracellular 2, 3-bisphosphoglycerate level, multiple tips in mound |
| iplA- | iplA | | abolished autophagic cell death, abolished autophagic vacuole formation, abolished cellulose biosynthesis |
| HM1038 | iplA- | iplA | | delayed aggregation, precocious aggregation |
| DBS0252878 | iptA- | iptA | | decreased spore viability |
| DBS0236031 | kctd9- | kctd9 | | wild type |
| DBS0236489 | kif12- | kif12 | | aberrant cytokinesis, aberrant myosin II organization |
| DBS0236490 | kif12-/[act15]: FLAG: kif12 | kif12 | | wild type |
| DBS0236491 | kil1- | kil1 | | abolished resistance to pathogenic bacteria |
| DBS0236757 | phg1a-/[act15]: kil1 | kil1, phg1a | phg1 | wild type |
| DBS0236492 | krsA- | krsA | Krs1 | decreased chemotaxis to cAMP |
| DBS0236493 | krsA-/[act15]: GFP: krsA | krsA | Krs1 | wild type |
| DBS0238720 | krsA- | krsA | Krs1 | aberrant response to hyperosmotic stress, abolished activation of adenylate cyclase, abolished streaming, decreased aggregate size, decreased cell size, decreased intracellular cAMP level, precocious culmination, precocious gene expression |
| DBS0238721 | krsA-/[act15]: GFP: krsA | krsA | Krs1 | wild type |
| DBS0238722 | krsA-/[act15]: GFP: krsA(K49R) | krsA | Krs1 | aberrant streaming |
| DBS0238723 | krsA-/[act15]: GFP: krsA(T173A) | krsA | Krs1 | abolished streaming |
| DBS0238724 | krsA-/[act15]: GFP: krsA(deltaKinase) | krsA | Krs1 | abolished streaming |
| DBS0238725 | krsA-/[act15]: GFP: krsA(deltaC) | krsA | Krs1 | aberrant streaming |
| DBS0238726 | krsA-/[act15]: GFP: krsA(deltaNS) | krsA | Krs1 | abolished streaming |
| DBS0236494 | ksnG- | ksnG | K7, KIF7 | aberrant cell motility |
| DBS0236495 | ku80- | ku80 | | increased sensitivity to DNA-damaging agents |
| AK127 | lagC- | lagC | GP150 | aberrant aggregation, development arrests at loose aggregate stage, increased aggregate size |
| DBS0236498 | lagD- | lagD | lagC2 | aberrant aggregation, aberrant cAMP signaling during aggregation, abolished streaming |
| DBS0236499 | limB- | limB | lim2, paxA | aberrant F-actin organization, aberrant cell-cell adhesion, abolished sorting to prestalk region, decreased cell polarity, decreased cell-substrate adhesion, decreased chemotaxis rate, decreased gene expression, delayed gene expression, development arrests at mound stage |
| DBS0236500 | limB-/[cotC]: limB | limB | lim2, paxA | development arrests at mound stage |
| DBS0236501 | limB-/[ecmAO]: limB | limB | lim2, paxA | wild type |
| DBS0236502 | limB-/[act15]: paxB: GFP | limB, paxB | lim2, paxA | development arrests at mound stage |
| DBS0236503 | limE- | limE | DdLim, crp | aberrant cytokinesis |
| DBS0236549 | mhcA-/[act15]: limE(1-145): GFP | limE, mhcA | DdLim, MHC, crp | increased F-actin polymerization |
| DBS0236506 | limF- | limF | | decreased phagocytosis |
| DG1006 | lipA- | lipA | ALOX, DG1006 | abolished culmination |
| DBS0236511 | lipA- | lipA | ALOX, DG1006 | wild type |
| DBS0236512 | lipA- | lipA | ALOX, DG1006 | wild type |
| DBS0236516 | lrrA- | lrrA | | aberrant cell morphology, abolished aggregation, abolished chemotaxis, decreased cell polarity, decreased cell-substrate adhesion, decreased gene expression, decreased spore viability, delayed gene expression, development arrests at mound stage, increased aggregate size, increased basal F-actin level |
| DBS0236517 | lst8- | lst8 | | aberrant activation of adenylate cyclase activity, abolished aggregation, decreased F-actin polymerization, decreased chemotaxis rate, decreased myosin II assembly |
| AD60 | lvsA- | lvsA | | aberrant contractile vacuole organization and biogenesis, aberrant response to hypo-osmotic stress, abolished cytokinesis, decreased phagocytosis, decreased pinocytosis, increased cell-substrate adhesion |
| AD63 | lvsA- | lvsA | | abolished cAMP-induced Ca2+ influx, abolished cytokinesis |
| DBS0236761 | phgA-/[act6]: GFP: lvsA | lvsA, phgA | rabGAP | aberrant protein localization |
| DBS0236521 | lvsB- | lvsB | | aberrant post-lysosome organization and biogenesis, increased exocytosis, increased lysosome size, increased secretion of lysosomal enzymes |
| DBS0236522 | lvsC- | lvsC | | wild type |
| DBS0236523 | lvsD- | lvsD | | wild type |
| DBS0236524 | lvsE- | lvsE | | wild type |
| DBS0236525 | lvsF- | lvsF | | wild type |
| DBS0236536 | malA- | malA | sigA | wild type |
| DBS0236543 | mekA- | mekA | DdMEK1, mek1 | decreased aggregate size, precocious development |
| HS1 | mhcA- | mhcA | MHC | aberrant protein localization |
| HK323 | mhcA- | mhcA | MHC | decreased cell motility |
| CW0401 | mhcA-/[act15]: mhcA(T1823A/T1833A/T2029A) | mhcA | MHC | decreased growth rate in suspension, increased myosin II assembly |
| HS2206 | mhcA- | mhcA | MHC | abolished bleb formation |
| HS2207 | mhcA- | mhcA | MHC | abolished cytokinesis, development arrests at mound stage |
| DBS0236550 | mhcA-/[act15]: mhcA(T1823A/T1833A/T2029A) | mhcA | MHC | decreased filopodium formation |
| DBS0236551 | mhcA-/[act15]: mhcA(T1823D/T1833D/T2029D) | mhcA | MHC | increased filopodium formation |
| DBS0236552 | mhcA-/[mhcA]: mhcA(1-1224) | mhcA | MHC | aberrant cytokinesis, development arrests at mound stage |
| DBS0238157 | mhcA-/[mhcA]: mhcA(1-1224)/[act15]: mhcA(R689H) | mhcA | MHC | decreased actin filament sliding |
| DBS0238158 | mhcA-/[act15]: mhcA(81-2116) | mhcA | MHC | decreased growth rate, development arrests at tipped mound stage |
| DBS0266674 | mhcA-/[act15]: GFP: abpC(9-148) | mhcA | MHC | decreased pseudopod retraction, decreased uropod retraction |
| DBS0266675 | mhcA-/[act15]: GFP: mhcA(E476K) | mhcA | MHC | decreased pseudopod retraction |
| DBS0236548 | mhcA-/[act15]: GFP: pats1(2087-2351) | mhcA, pats1 | MHC | aberrant cytokinesis |
| DBS0238399 | mhcA-/[act15]: rapA(G12V) | mhcA, rapA | MHC, rap1 | aberrant myosin II organization, increased basal F-actin level, increased cell polarity |
| CW0371 | mhkA- | mhkA | MHCK-A | increased myosin II assembly |
| DBS0236557 | mhkA-/[act15]: mhkA | mhkA | MHCK-A | aberrant cytokinesis, decreased growth rate in suspension, decreased myosin II assembly, development arrests at mound stage |
| CW0166 | mhkB- | mhkB | MHCK-B | increased myosin II assembly |
| CW0403 | mhkC- | mhkC | DG1069, MHCK-C | aberrant cytokinesis, increased myosin II assembly |
| DG1069 | mhkC- | mhkC | DG1069, MHCK-C | aberrant fruiting body morphology |
| CW0435 | mhkD- | mhkD | MHCK-D | increased myosin II assembly |
| DBS0236559 | midA- | midA | | aberrant spore morphology, decreased cell size, decreased growth rate in suspension, decreased growth rate on bacterial plates, decreased intracellular glycogen level, increased extracellular ammonia level, increased intracellular glutamate level, increased slug migration |
| DG1020 | migA- | migA | DG1020 | aberrant fruiting body morphology, abolished slug migration, small fruiting body |
| DBS0236560 | mkcA- | mkcA | DG1023 | decreased gene expression |
| DG1101 | mkcB- | mkcB | DG1101 | small fruiting body |
| DBS0236564 | mkkA- | mkkA | MEKKalpha | decreased sorus size, increased stalk length, precocious culmination |
| DG1121 | mkpA- | mkpA | DG1121 | abolished aggregation |
| DBS0236566 | mlcE- | mlcE | EMLC | aberrant cytokinesis, aberrant development, decreased cell motility, decreased growth rate in suspension, delayed aggregation, mislocalized gene expression |
| DBS0238058 | mlcE-/[act15]: myc: mlcE | mlcE | EMLC | wild type |
| DBS0236567 | mlcR- | mlcR | RMLC | aberrant cytokinesis, aberrant myosin II organization, development arrests at mound stage |
| HS183 | mlkA- | mlkA | MLCK, MLCK-A | aberrant cytokinesis |
| DG1033 | modA- | modA | DG1033 | aberrant fruiting body morphology |
| rps4OE | mrps4- | mrps4 | dia3, rps4 | aberrant fruiting body morphology, delayed aggregation |
| DBS0237709 | mybE-/[mrrA]: lacZ | mrrA, mybE | | aberrant prestalk cell differentiation |
| DBS0236570 | mybB- | mybB | Ddmyb2, myb2 | abolished aggregation, decreased activation of adenylate cyclase, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased gene expression |
| DBS0236571 | mybB- | mybB | Ddmyb2, myb2 | abolished aggregation |
| HM388 | mybC- | mybC | | abolished culmination, decreased SDF production, decreased gene expression |
| DBS0236572 | mybE- | mybE | | increased slug size |
| DBS0236573 | mybE-/mybE: GFP | mybE | | aberrant prestalk cell differentiation, wild type |
| HDT1 | myoA- | myoA | DMIA, abmA, myoIA | decreased cell motility, decreased chemotaxis rate, decreased lateral pseudopod suppression, delayed aggregation |
| HDT2 | myoA- | myoA | DMIA, abmA, myoIA | increased secretion of lysosomal enzymes |
| DBS0236579 | myoB- | myoB | DMIB, abmB, myoIB | increased secretion of lysosomal enzymes |
| DBS0236580 | myoB- | myoB | DMIB, abmB, myoIB | decreased cell motility, decreased lateral pseudopod suppression, decreased phagocytosis, delayed aggregation |
| DBS0236584 | myoB-/[AS]myoD/[KD]myoC | myoB, myoC, myoD | DMIB, DMIC, DMID, abmB, abmC, myoIB, myoIC, myoID | aberrant aggregation, decreased aggregate size, decreased cell motility, decreased growth rate, decreased phagocytosis, decreased pinocytosis, increased number of pinosomes, small pinosomes |
| DBS0236583 | myoB-/[AS]myoD | myoB, myoD | DMIB, DMID, abmB, myoIB, myoID | aberrant aggregation, decreased aggregate size, decreased cell motility, decreased growth rate, decreased phagocytosis, decreased pinocytosis |
| DBS0236585 | myoC- | myoC | DMIC, abmC, myoIC | decreased phagocytosis |
| DBS0236587 | myoD- | myoD | DMID, myoID | wild type |
| HDT8 | myoF- | myoF | myoIF | wild type |
| HDT17 | myoI- | myoI | DdMVII, M7, MVII | decreased cell-cell adhesion, decreased cell-substrate adhesion, decreased filopodium formation, decreased phagocytosis |
| DBS0236589 | myoI- | myoI | DdMVII, M7, MVII | decreased spore germination |
| DBS0236592 | myoI- | myoI | DdMVII, M7, MVII | aberrant cell morphology, aberrant cytokinesis |
| HTD7 | myoJ- | myoJ | myo5B | wild type |
| DBS0236595 | myoM- | myoM | RacGEF | wild type |
| SB12 | napA- | napA | Nap1, Nap125 | decreased basal F-actin level, decreased cell motility, decreased cell polarity, decreased cell size, decreased cell-cell adhesion, decreased cell-substrate adhesion, decreased phototaxis |
| HC476 | ncsA- | ncsA | | increased intracellular cAMP level, precocious development, precocious gene expression |
| HC477 | ncsA- | ncsA | | increased intracellular cAMP level, precocious development, precocious gene expression |
| DBS0236604 | nhe1- | nhe1 | DdNHE1 | aberrant F-actin organization, decreased cell polarity, decreased chemotaxis rate, decreased intracellular pH level |
| DBS0236605 | nhe1-/[act15]: nhe1: HA | nhe1 | DdNHE1 | wild type |
| DBS0235950 | nosA- | nosA | | development arrests at mound stage |
| DBS0236606 | nosA null (15-S-12) | nosA | | development arrests at mound stage |
| DBS0236607 | nosA null (2E4) | nosA | | development arrests at mound stage |
| DBS0236840 | R7 | nosA | | development arrests at mound stage |
| DBS0236608 | noxA- | noxA | gp91phox | aberrant development, abolished sporulation |
| DBS0236611 | noxA-/[act15]: noxA: myc2 | noxA | gp91phox | aberrant fruiting body morphology |
| DBS0236612 | noxB- | noxB | gp91phox | aberrant development, abolished sporulation, decreased superoxide production |
| DBS0236613 | noxC- | noxC | gp91phox | aberrant development, abolished sporulation |
| DBS0238849 | npcA- | npcA | | wild type |
| DBS0236695 | nramp1- | nramp1 | NRAMP, Slc11a1 | abolished iron ion transport, increased infection rate by Legionella pneumophila, increased infection rate by Mycobacterium avium |
| DBS0236696 | nramp1-/[act15]: nramp1: GFP | nramp1 | NRAMP, Slc11a1 | decreased infection rate by Legionella pneumophila |
| DBS0236697 | nramp1-/[act15]: nramp1: GFP | nramp1 | NRAMP, Slc11a1 | decreased infection rate by Legionella pneumophila |
| DBS0236955 | nxnA- | nxnA | ANN7, DdANN7, quit3, synexin | decreased chemotaxis to cAMP, decreased culmination, decreased growth rate, decreased lysosomal enzyme activity, delayed development |
| DBS0236704 | osbA- | osbA | OSBPa | increased slug migration, precocious development |
| DBS0238357 | p2xA- | p2xA | DdP2X | aberrant response to hypo-osmotic stress |
| DBS0238362 | p2xA-/[act15]: p2xA: GFP | p2xA | DdP2X | wild type |
| DBS0236705 | pakA- | pakA | DPAKa, dpak1 | aberrant cytokinesis, delayed development |
| DBS0236706 | pakA- | pakA | DPAKa, dpak1 | wild type |
| DBS0236707 | pakA-/[act15]: pakA | pakA | DPAKa, dpak1 | wild type |
| DBS0236709 | pakB- | pakB | Ddpak, mihck | decreased growth rate |
| DBS0236710 | pakB-/[act15]: GFP-pak(1-337): (563-851) | pakB | Ddpak, mihck | abolished cytokinesis, increased phagocytosis, increased pinocytosis |
| DBS0236712 | pakB-/[act15]: GFP-pak(1-~600) | pakB | Ddpak, mihck | abolished cytokinesis |
| DBS0236716 | PAKc- | pakC | | decreased chemotaxis rate, decreased lateral pseudopod suppression |
| HC392 | patB- | patB | PAT2 | abolished growth in acidic medium, abolished growth on bacterial plates |
| DBS0236726 | pats1- | pats1 | | aberrant cytokinesis |
| DBS0236727 | pats1-/[act15]: GFP: pats1(2087-2351) | pats1 | | aberrant cytokinesis |
| DBS0236728 | paxB- | paxB | | aberrant fruiting body morphology, decreased cell-substrate adhesion, decreased gene expression, decreased sorting to prestalk region, development arrests at mound stage |
| DBS0236730 | paxB-/[ecmA]: paxB: GFP | paxB | | decreased sorting to prestalk region |
| DBS0236732 | paxB-/[pspA]: paxB: GFP | paxB | | decreased sorting to prestalk region |
| DBS0236733 | pcp- | pcp | | wild type |
| DBS0236734 | pde4- | pde4 | DdPDE4 | decreased culmination, delayed culmination, delayed slug formation |
| DBS0236735 | pde4-/[act15]: pde4: GFP | pde4 | DdPDE4 | wild type |
| DBS0236736 | pdeD- | pdeD | DdPDE5, gbpA, pde5 | decreased Ca2+-induced Ca2+ influx, decreased cAMP-induced Ca2+ influx, delayed cAMP-induced Ca2+ influx |
| UK7 | pdsA- | pdsA | DdPDE1, PDE, pde1, pdeA | abolished aggregation, decreased 3', 5'-cyclic-AMP phosphodiesterase activity |
| DBS0236741 | pefA- | pefA | ALG-2, DdPEF-1, alg2, alg2A, pef1 | wild type |
| DBS0236744 | pefB- | pefB | ALG-2, DdPEF-2, alg-2B, alg2, alg2B, pef2 | wild type |
| HW260 | pgtA- | pgtA | FT85, fucB | increased cell size |
| DBS0236752 | phdA- | phdA | DG1093 | decreased aggregate size, decreased basal F-actin level, decreased chemotaxis rate, small fruiting body |
| DBS0236753 | phdA-/[act15]: phdA | phdA | DG1093 | wild type |
| DBS0236754 | phdA-/[act15]: phdA: GFP | phdA | DG1093 | wild type |
| DBS0236755 | phg1a- | phg1a | phg1 | aberrant cytokinesis, abolished resistance to pathogenic bacteria, decreased cell-substrate adhesion, decreased phagocytosis |
| DBS0236758 | phg2- | phg2 | | aberrant F-actin organization, aberrant cell morphology, aberrant cytokinesis, aberrant response to nutrients, decreased cell motility, decreased cell-substrate adhesion, decreased phagocytosis, precocious development, precocious gene expression |
| DBS0236760 | phg2-/[act15]: GFP: phg2(199-1389) | phg2 | | decreased phagocytosis |
| DBS0238400 | phg2- | phg2 | | aberrant cell morphology, decreased chemotaxis to cAMP, increased basal F-actin level, increased cell-substrate adhesion, increased filopodium formation, increased phagocytosis |
| DBS0236762 | phlp1- | phlp1 | | aberrant protein localization, aberrant regulation of protein modification, abolished aggregation, abolished chemotaxis, decreased cAMP-induced cAMP pulse, decreased cAMP-induced cGMP pulse, decreased growth rate in suspension, decreased growth rate on bacterial plates |
| DBS0236763 | phlp1-/[OE]: phpl1 | phlp1 | | wild type |
| DBS0236764 | phlp3- | phlp3 | | wild type |
| HW288 | phyA- | phyA | P4H1 | wild type |
| DBS0236767 | pia- | piaA | DG1117, Pianissimo, amiA, pia | aberrant activation of adenylate cyclase activity |
| DBS0236770 | piaA- | piaA | DG1117, Pianissimo, amiA, pia | aberrant cytokinesis |
| DBS0236771 | piaA- | piaA | DG1117, Pianissimo, amiA, pia | abolished aggregation, decreased myosin II assembly |
| DBS0236772 | pikA- | pikA | PI3K, PI3K1, PIK1 | wild type |
| DBS0236774 | pikB- | pikB | PI3K2, PIK2 | wild type |
| DBS0236776 | pikC- | pikC | PI3K3, PIK3 | wild type |
| DBS0236777 | pikD1 | pikD | PI4Kbeta, PIK4 | aberrant fruiting body morphology, abolished slug migration, decreased aggregate size, decreased number of spores, delayed aggregation |
| DBS0236778 | pikE- | pikE | DdPIK5, PIK5, VPS34 | wild type |
| DBS0236793 | PLC- (HD1.19) | pipA | DdPLC, plc | aberrant negative chemotaxis |
| DBS0236794 | PLC- (HD10) | pipA | DdPLC, plc | wild type |
| DBS0236779 | PIPkinA- | PIPkinA | Ddpik6, PIK6 | abolished aggregation, decreased gene expression |
| SB3 | pirA- | pirA | PIR121 | decreased cell motility, increased basal F-actin level, increased cell size, increased pseudopod formation |
| SB16 | pirA- | pirA | PIR121 | decreased cell size, increased cell motility |
| DBS0236783 | PKAcat- | pkaC | DdPK2, DdPK3, PK2, PK3, PKA, PKA-C, cAK, pkacat | abolished aggregation |
| HTY506 | HTY506 | pkaR | PKA, cAK, rdeC | aberrant fruiting body morphology, aberrant spore morphology, decreased phosphorylation of actin, decreased spore viability, increased sporulation, precocious development |
| DBS0235411 | pka | |
